These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 23626572)
1. Acute-Onset Endophthalmitis Caused by Alloiococcus otitidis following a Dexamethasone Intravitreal Implant. Marchino T; Vela JI; Bassaganyas F; Sánchez S; Buil JA Case Rep Ophthalmol; 2013 Jan; 4(1):37-41. PubMed ID: 23626572 [TBL] [Abstract][Full Text] [Related]
2. CASE REPORT OF ABIOTROPHIA DEFECTIVA ENDOPHTHALMITIS AFTER REPEATED INJECTIONS OF DEXAMETHASONE INTRAVITREAL IMPLANT (OZURDEX). Cruz-Iñigo YJ; Klein K; Reddy RK Retin Cases Brief Rep; 2022 Mar; 16(2):170-173. PubMed ID: 31479011 [TBL] [Abstract][Full Text] [Related]
3. Acute Onset of Exogenous Endophthalmitis after Dexamethasone Implant Injection Treated without Implant Removal. Bastakis GG; Stavrakakis A; Nikolaos A; Dimopoulos D; Pappas G Case Rep Ophthalmol Med; 2018; 2018():4614802. PubMed ID: 30581640 [TBL] [Abstract][Full Text] [Related]
4. Suspected bacterial endophthalmitis following sustained-release dexamethasone intravitreal implant: a case report. Arıkan Yorgun M; Mutlu M; Toklu Y; Cakmak HB; Cağıl N Korean J Ophthalmol; 2014 Jun; 28(3):275-7. PubMed ID: 24882964 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of dexamethasone intravitreal implant in patients with retinal vein occlusion resistant to anti-VEGF therapy: a 12-month prospective study. Georgalas L; Tservakis I; Kiskira EE; Petrou P; Papaconstantinou D; Kanakis M Cutan Ocul Toxicol; 2019 Dec; 38(4):330-337. PubMed ID: 31060385 [No Abstract] [Full Text] [Related]
6. TWO CASES OF ACUTE ENDOPHTHALMITIS AFTER INTRAVITREAL DEXAMETHASONE IMPLANT INJECTION. Esen E; Sizmaz S; Demircan N Retin Cases Brief Rep; 2016; 10(2):154-6. PubMed ID: 26426482 [TBL] [Abstract][Full Text] [Related]
7. Resolution of Persistent Cystoid Macular Edema due to Central Retinal Vein Occlusion in a Vitrectomized Eye following Intravitreal Implant of Dexamethasone 0.7 mg. Reibaldi M; Russo A; Zagari M; Toro M; Grande De V; Cifalinò V; Rametta S; Faro S; Longo A Case Rep Ophthalmol; 2012 Jan; 3(1):30-4. PubMed ID: 22615698 [TBL] [Abstract][Full Text] [Related]
8. ACUTE ATYPICAL ENDOPHTHALMITIS FOLLOWING INTRAVITREAL SUSTAINED-RELEASE DEXAMETHASONE IMPLANT: A CASE SERIES. Chin YYB; Yeo TH; Bakthavatsalu M; Zhou WT; Wagle AM; Gopal L; Lim TH Retin Cases Brief Rep; 2024 Mar; 18(2):155-158. PubMed ID: 36730427 [TBL] [Abstract][Full Text] [Related]
9. Endophthalmitis after Intravitreal Injection of Vascular Endothelial Growth Factor Inhibitors: Management and Visual Outcomes. Xu K; Chin EK; Bennett SR; Williams DF; Ryan EH; Dev S; Mittra RA; Quiram PA; Davies JB; Parke DW; Johnson JB; Cantrill HL; Almeida DRP Ophthalmology; 2018 Aug; 125(8):1279-1286. PubMed ID: 29477689 [TBL] [Abstract][Full Text] [Related]
10. Acute bacterial endophthalmitis following intravitreal dexamethasone implant: A case report and review of literature. Goel N Saudi J Ophthalmol; 2017; 31(1):51-54. PubMed ID: 28337065 [TBL] [Abstract][Full Text] [Related]
11. SD-OCT pattern of retinal venous occlusion with cystoid macular edema treated with Ozurdex®. Coscas G; Coscas F; Zucchiatti I; Glacet-Bernard A; Soubrane G; Souïed E Eur J Ophthalmol; 2011; 21(5):631-6. PubMed ID: 21500185 [TBL] [Abstract][Full Text] [Related]
12. Comparison of intravitreal bevacizumab upload followed by a dexamethasone implant versus dexamethasone implant monotherapy for retinal vein occlusion with macular edema. Mayer WJ; Remy M; Wolf A; Kook D; Kampik A; Ulbig M; Reznicek L; Haritoglou C Ophthalmologica; 2012; 228(2):110-6. PubMed ID: 22739239 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of Multiple Dexamethasone Intravitreal Implants for Refractory Retinal Vein Occlusion-Related Macular Edema and Effect of Prior Vitrectomy. Houben I; De Zaeytijd J; Deghislage C; Frost NA; Nijs I; Van Calster J J Ocul Pharmacol Ther; 2018 Dec; 34(10):710-719. PubMed ID: 30403557 [No Abstract] [Full Text] [Related]
14. Functional and anatomical results after a single intravitreal Ozurdex injection in retinal vein occlusion: a 6-month follow-up -- the SOLO study. Bezatis A; Spital G; Höhn F; Maier M; Clemens CR; Wachtlin J; Lehmann F; Hattenbach LO; Feltgen N; Meyer CH Acta Ophthalmol; 2013 Aug; 91(5):e340-7. PubMed ID: 23638803 [TBL] [Abstract][Full Text] [Related]
15. Acute Bacterial Endophthalmitis Following Dexamethasone Intravitreal Implant: A Case Report. Al Zamil W; Yassin SA Saudi J Med Med Sci; 2019; 7(2):110-113. PubMed ID: 31080392 [TBL] [Abstract][Full Text] [Related]
17. The Effect of Age and Initial Central Retinal Thickness on Earlier Need of Repeat Ozurdex Treatment for Macular Edema Due to Retinal Vein Occlusion: A Retrospective Case Series. Lin CJ; Chen HS; Su CW; Tien PT; Lin JM; Chen WL; Kuo CY; Lai CT; Tsai YY J Ocul Pharmacol Ther; 2017 Dec; 33(10):763-772. PubMed ID: 28949790 [TBL] [Abstract][Full Text] [Related]
18. Intravitreal Dexamethasone Implant versus Intravitreal Ranibizumab for the Treatment of Macular Edema Secondary to Retinal Vein Occlusion in a Chinese Population. Gu X; Yu X; Song S; Dai H Ophthalmic Res; 2017; 58(1):8-14. PubMed ID: 28334720 [TBL] [Abstract][Full Text] [Related]
19. Management and Visual Outcomes of Acute Bacterial Endophthalmitis Following Intravitreal Injection of Contaminated Bevacizumab in a Single Day. Xu K; Mousa R; Loewenstein A; Barak A; Chin EK; Almeida DRP Ophthalmic Surg Lasers Imaging Retina; 2020 Jun; 51(6):346-352. PubMed ID: 32579693 [TBL] [Abstract][Full Text] [Related]